Read + Share
Klein O, Kee D, Markman B, Carlino MS, et al. Evaluation of TMB as a predictive biomarker in patients with solid cancers
treated with anti-PD-1/CTLA-4 combination immunotherapy. Cancer Cell 2021;39:592-593.
PMID: 33930312
|
 |
|
Klein O, Kee D, Markman B, Carlino MS, et al. Evaluation of TMB as a predictive biomarker in patients with solid cancers
treated with anti-PD-1/CTLA-4 combination immunotherapy. Cancer Cell 2021;39:592-593.
PMID: 33930312
|
|
|
|